Pira et al._Supplementary Tables and autoimmune Bullous Diseases Study Group

Description

Supplementary files (Tables and List of participants to Autoimmune Bullous Diseases Study Group) related to the published paper on The Journal of American Academy of Dermatology titled "Linagliptin is a risk factor for bullous pemphigoid associated with BP180-NC16A/BP230 seronegativity and milder severity: evidence from a prospective case-control study supporting ECD-BP180 ELISA in reducing diagnostic delay"

Steps to reproduce

The data were obtained by a case-control study

Institutions

• Istituto Dermopatico dell'Immacolata

  Lazio, Rome

Categories

Licence